pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

8,127 products tracked · 1,561 matching

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health
viewlistcards
  • Phase 2
    LXP-109
    Non-Small Cell Lung Cancer LaunXP Biomedical Co Ltd
  • Phase 2
    LXP-5268
    Triple-Negative Breast Cancer (TNBC) LaunXP Biomedical Co Ltd
  • Phase 2
    LYGLIV-0001
    Liver Diseases LyGenesis Inc
  • Phase 2
← prev
page 18 of 53
next →
131
Pain89
Neurology1
LYT-200
Liver Cancer
Gallop Oncology Inc
  • Phase 2
    Lyophilized Microbiota
    Mutational Disorders Gut-Brain Axis Therapeutics LLC
  • Phase 2
    M-032
    Anaplastic Astrocytoma UAB Minority Health and Health Equity Research Center
  • Phase 2
    MAI-001
    Depression Nanjing Mainowei Pharmaceutical Technology Co Ltd.
  • Phase 2
    MANP
    Resistant Hypertension E-Star BioTech LLC
  • Phase 2
    MB-105
    Cutaneous T-Cell Lymphoma March Biosciences
  • Phase 2
    MC-001
    Spinal Cord Injury StemCyte Inc
  • Phase 2
    MC-232
    Hidradenitis Suppurativa MC2 Therapeutics AS
  • Phase 2
    MDI-1228
    Diabetic Foot Ulcers Henan Maiyingnuo Pharmaceutical Technology Co Ltd
  • Phase 2
    MDNA-11
    Solid Tumor$MDNAF Medicenna Therapeutics Corp.
  • Phase 2
    MDX-1097
    Refractory Multiple Myeloma HaemaLogix Pty Ltd
  • Phase 2
    MEDI-0457
    Oropharyngeal Cancer$AZN ASTRAZENECA PLC
  • Phase 2
    MET-224o
    Obesity Metsera Inc
  • Phase 2
    MET-233i
    Obesity Metsera Inc
  • Phase 2
    METHOTREXATE
    METHOTREXATE
    Retinitis Pigmentosa (Retinitis)$ALDX Aldeyra Therapeutics, Inc.
  • Phase 2
    MGD-014
    Human Immunodeficiency Virus (HIV) Infections (AIDS)$MGNX MACROGENICS INC
  • Phase 2
    MHB-018A
    Graves' Ophthalmopathy Minghui Pharmaceutical (Shanghai) Co Ltd
  • Phase 2
    MIT-001
    Oral Mucositis MitoImmune Therapeutics Inc
  • Phase 2
    MIV-711
    Osteoarthritis Medivir AB
  • Phase 2
    MK-2214
    Alzheimer's Disease$MRK Merck & Co., Inc.
  • Phase 2
    MK-3795
    Von Hippel-Lindau Syndrome$MRK Merck & Co., Inc.
  • Phase 2
    MK-6194
    Ulcerative Colitis$MRK Merck & Co., Inc.
  • Phase 2
    MNV-101
    Pearson Syndrome Minovia Therapeutics Ltd
  • Phase 2
    MNV-201
    Pearson Syndrome Minovia Therapeutics Ltd
  • Phase 2
    MORF-057
    Crohn's Disease (Regional Enteritis) Eli Lilly and Co
  • Phase 2
    MP-0712
    Neuroendocrine Tumors$MOLN MOLECULAR PARTNERS AG
  • Phase 2
    MP-101
    dimiracetam [INN]
    Amyotrophic Lateral Sclerosis Mitochon Pharmaceuticals Inc